Skip to content

Commit 64203a9

Browse files
update journal-publications.md
1 parent 2e0a196 commit 64203a9

1 file changed

Lines changed: 1 addition & 0 deletions

File tree

journal-publications.md

Lines changed: 1 addition & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -1,5 +1,6 @@
11
Year|Title|URL|Source|DOI
22
-|-|-|-|-
3+
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/738">Physiologically-based pharmacokinetic modeling of belimumab for systemic lupus erythematosus patients to predict the withdrawal time in pregnancy and vaccine time in infants</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/42086179/">https://pubmed.ncbi.nlm.nih.gov/42086179/</a>|Eur J Pharm Sci. 2026 Jul 1:222:107545.|<a href="https://doi.org/10.1016/j.ejps.2026.107545">10.1016/j.ejps.2026.107545</a>
34
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/736">Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/42130310/">https://pubmed.ncbi.nlm.nih.gov/42130310/</a>|J Clin Pharmacol. 2026 May;66(5):e70205.|<a href="https://doi.org/10.1002/jcph.70205">10.1002/jcph.70205</a>
45
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/734">A unified physiologically based pharmacokinetic model for low-to-high oral, subcutaneous, and intravenous dose of methotrexate in humans</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/42235850/">https://pubmed.ncbi.nlm.nih.gov/42235850/</a>|J Pharm Sci. 2026 Jun 2;115(8):104348.|<a href="https://doi.org/10.1016/j.xphs.2026.104348">10.1016/j.xphs.2026.104348</a>
56
2026|<a href="https://github.com/Open-Systems-Pharmacology/OSP-based-publications-and-content/issues/733">Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing</a>|<a href="https://pubmed.ncbi.nlm.nih.gov/42305545/">https://pubmed.ncbi.nlm.nih.gov/42305545/</a>|Front Immunol. 2026 Jun 1:17:1847997.|<a href="https://doi.org/10.3389/fimmu.2026.1847997">10.3389/fimmu.2026.1847997</a>

0 commit comments

Comments
 (0)